Alkixen (Crizotinib) 250 MG – 60 CAPSULES


Crizotinib (Alkixen) is a kinase inhibitor used to treat metastatic non-small cell lung cancer (NSCLC) in patients with ALK or ROS1 positive tumors, confirmed by an FDA-approved test. It’s also indicated for pediatric patients (1 year and older) and young adults with relapsed or refractory ALK-positive systemic anaplastic large cell lymphoma (ALCL).

Whatsapp +8801922101029